Effects of lymph node metastasis of thoracic esophageal squamous cell carcinoma on design of radiotherapy target volume

Abstract

Objective: To analyze the correlation between lymph node metastasis of thoracic esophageal squamous cell carcinoma (ESCC) and clinical and pathological factors, and to provide a reference for the outline of clinical target volume.
 Methods: The pathological characteristics of 1034 thoracic ESCC patients after surgery were described, and the correlations between clinical and pathological factors and lymph node metastasis were studied by univariate and Logistic multivariate analyses.
 Results: Lymph node metastasis was significantly correlated with tumor length, invasion depth and differentiation degree (P<0.01), but not gender, age, tumor site or pathological type (P>0.05). Logistic multivariate analysis showed that tumor length, invasion depth and differentiation degree were independent risk factors for thoracic ESCC. The lymph node metastasis rates of mid-thoracic ESCC in the middle mediastinum, lower-thoracic ESCC in the lower mediastinum and abdominal cavity were 18.5%, 35.3% and 19.7% respectively in the T1-T2 stage. In the T3-T4 stage, the lymph node metastasis rates of mid-thoracic ESCC in the middle mediastinum and abdominal cavity were 39.6% and 17.4% respectively, and those of lower-thoracic ESCC in middle and lower mediastina and abdominal cavity were 21.1%, 43.4% and 29.8% respectively. Highly/moderately differentiated mid-thoracic ESCC in the middle mediastinum, lower-thoracic ESCC in middle and lower mediastina and abdominal cavity had the lymph node metastasis rates of 34.7%, 15.1%, 33.5% and 23.7% respectively. Lowly differentiated mid-thoracic ESCC in the middle mediastinum and abdominal cavity had the lymph node metastasis rates of 46.9% a 29.6% respectively, and those of lower-thoracic ESCC in middle and lower mediastina and abdominal cavity were 25.5%, 49.1% and 27.3% respectively.
 Conclusion: During the outline of radiotherapy target volume for thoracic ESCC, tumor length, invasion depth and differentiation degree should be comprehensively considered to selectively irradiate the regions prone to lymph node metastasis.
 How to cite this:Pan G, Pan H, Zhang Y, Shuai H. Effects of lymph node metastasis of thoracic esophageal squamous cell carcinoma on design of radiotherapy target volume. Pak J Med Sci. 2019;35(1):177-182. doi: https://doi.org/10.12669/pjms.35.1.431
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Lymph Node Metastases Status in Esophageal Squamous Cell Carcinoma following Neoadjuvant Chemoradiotherary: A Single-Center Prospective Study

“…Our study observed a low LN metastase rate of 4.11% with a median of 2 metastatic LN (range, 1-20). Compared to Goubing Pan's study, the LN metastase rates for middle-third and lower-third ESCC were 30.7% and 15.7%, respectively (13). This demonstrates that NCRT signi cantly reduces the rate of LN metastases.…”

Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with small cell carcinoma of the esophagus: A multicenter retrospective trial from China (CHiSCEC)

“…Therefore, an accurate outline of the target volume for lymphatic drainage is of great signi cance for delineating clinical target areas [17]. CTVs have two components: subclinical invasion and intramural metastasis of the primary tumor (CTVp) and subclinical lymph nodes (CTVn) [18].…”

Diagnostic value of contrast-enhanced ultrasound combined with MRI for cervical hyperplastic, tuberculosis-infected, and metastatic lymph nodes

“…2,3 Clinical diagnosis of cervical lymph node diseases is mainly arrived at through puncture and surgical pathology or though imaging examinations. 3,5 Fig. 2: Multiple enlarged lymph nodes were detected in right cervical region II, and the larger ones were about 2.3×1.3cm, cortex thickened, internal echo was disordered and uneven, and lymphatic hilum disappeared.…”

“… 2 , 3 Clinical diagnosis of cervical lymph node diseases is mainly arrived at through puncture and surgical pathology or though imaging examinations. 3 , 5 Because of the complex influencing factors of cervical LN enlargement, some patients cannot be diagnosed after puncture or surgical pathology examinations alone. 6 With the development of imaging techniques, CEUS and MRI have been widely used for diagnosing various tumoral diseases.…”